identification and assessment of a potential anti-breast cancer activity of antimicrobial peptide retrieved from the ATMP1 fish peptide.

A previous study has shown that synthetic antimicrobial peptides (AMPs) derived from (ATMP1) could inhibit the progression of breast cancer cell lines. In this study, we are interested in studying altered versions of previous synthetic AMPs to gain some insight into the peptides functions. The AMPs were altered and subjected to bioinformatics prediction using four databases (ADP3, CAMP-R3, AMPfun, and ANTICP) to select the highest anticancer activity.